Machine learning is increasingly used to predict post-surgical complications, but predictive performance does not guarantee clinical readiness. Shimizu and colleagues developed a promising model for older adults undergoing tibial fracture surgery using a large Japanese database. However, four methodological pitfalls warrant attention. First, the composite outcome was not validated in this population, and excluding in-hospital deaths introduced survivorship bias, underestimating the true burden of severe complications. Second, days to surgery, a variable not known at admission, created target leakage that inflates performance and undermines the admission-time claim. Third, using the test set for feature selection violated TRIPOD guidelines and likely overstated the scorecard's utility. Fourth, the Super Learner exhibited substantial overfitting, with a 0.110 drop between training (AUC = 0.850) and test (AUC = 0.740) performance, while offering only marginal improvement over simpler models. We suggest redeveloping the model with proper internal validation, excluding leakage-prone predictors, treating death as a competing risk, and prioritizing interpretability when complex ensembles offer limited added value. External validation remains essential before clinical implementation.
No takes yet. Share an insight, caveat, or question.
Shukhrat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: